Search

Ted M. Wang

Examiner (ID: 15234, Phone: (571)272-3053 , Office: P/2633 )

Most Active Art Unit
2633
Art Unit(s)
2634, 2633, 2611
Total Applications
1542
Issued Applications
1399
Pending Applications
39
Abandoned Applications
107

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11469669 [patent_doc_number] => 20170056453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-02 [patent_title] => 'FERTILIZED EGG ISOLATE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/094816 [patent_app_country] => US [patent_app_date] => 2016-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16506 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15094816 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/094816
FERTILIZED EGG ISOLATE AND USES THEREOF Apr 7, 2016 Abandoned
Array ( [id] => 11441956 [patent_doc_number] => 20170042977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-16 [patent_title] => 'METHODS AND COMPOSITIONS FOR CNS DELIVERY OF HEPARAN N-SULFATASE' [patent_app_type] => utility [patent_app_number] => 15/077046 [patent_app_country] => US [patent_app_date] => 2016-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 44746 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15077046 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/077046
METHODS AND COMPOSITIONS FOR CNS DELIVERY OF HEPARAN N-SULFATASE Mar 21, 2016 Abandoned
Array ( [id] => 11441956 [patent_doc_number] => 20170042977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-16 [patent_title] => 'METHODS AND COMPOSITIONS FOR CNS DELIVERY OF HEPARAN N-SULFATASE' [patent_app_type] => utility [patent_app_number] => 15/077046 [patent_app_country] => US [patent_app_date] => 2016-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 44746 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15077046 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/077046
METHODS AND COMPOSITIONS FOR CNS DELIVERY OF HEPARAN N-SULFATASE Mar 21, 2016 Abandoned
Array ( [id] => 11441959 [patent_doc_number] => 20170042978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-16 [patent_title] => 'CNS DELIVERY OF THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 15/016141 [patent_app_country] => US [patent_app_date] => 2016-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 147 [patent_figures_cnt] => 147 [patent_no_of_words] => 93228 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15016141 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/016141
CNS delivery of therapeutic agents Feb 3, 2016 Issued
Array ( [id] => 11002554 [patent_doc_number] => 20160199503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-14 [patent_title] => 'MODIFIED BLOOD FACTORS COMPRISING A LOW DEGREE OF WATER SOLUBLE POLYMER' [patent_app_type] => utility [patent_app_number] => 14/991172 [patent_app_country] => US [patent_app_date] => 2016-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15966 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14991172 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/991172
MODIFIED BLOOD FACTORS COMPRISING A LOW DEGREE OF WATER SOLUBLE POLYMER Jan 7, 2016 Abandoned
Array ( [id] => 11728018 [patent_doc_number] => 20170189461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-06 [patent_title] => 'METHOD OF PREPARING FERMENTED CRUDE EXTRACT HAVING ANGIOTENSIN CONVERTING ENZYME INHIBITING ACTIVITY' [patent_app_type] => utility [patent_app_number] => 14/985810 [patent_app_country] => US [patent_app_date] => 2015-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4104 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14985810 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/985810
Method of preparing fermented crude extract having angiotensin converting enzyme inhibiting activity Dec 30, 2015 Issued
Array ( [id] => 10782964 [patent_doc_number] => 20160129121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-12 [patent_title] => 'FACTOR VIIA-POLYSIALIC ACID CONJUGATES HAVING PROLONGED IN VIVO HALF-LIFE' [patent_app_type] => utility [patent_app_number] => 14/946286 [patent_app_country] => US [patent_app_date] => 2015-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9233 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14946286 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/946286
Factor VIIa-polysialic acid conjugates having prolonged in vivo half-life Nov 18, 2015 Issued
Array ( [id] => 13079443 [patent_doc_number] => 10059779 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-28 [patent_title] => Enzymatically polymerized gelling dextrans [patent_app_type] => utility [patent_app_number] => 14/933128 [patent_app_country] => US [patent_app_date] => 2015-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 34989 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14933128 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/933128
Enzymatically polymerized gelling dextrans Nov 4, 2015 Issued
Array ( [id] => 10705818 [patent_doc_number] => 20160051965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-25 [patent_title] => 'ABSORBANT AND DIGESTER FOR CARBON-BASED SUBSTANCES SUCH AS OIL' [patent_app_type] => utility [patent_app_number] => 14/830723 [patent_app_country] => US [patent_app_date] => 2015-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1851 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14830723 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/830723
ABSORBANT AND DIGESTER FOR CARBON-BASED SUBSTANCES SUCH AS OIL Aug 18, 2015 Abandoned
Array ( [id] => 15057239 [patent_doc_number] => 10458916 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-29 [patent_title] => Rapid tests for the detection of inhibitors of enzymes and human exposure to the same [patent_app_type] => utility [patent_app_number] => 14/827674 [patent_app_country] => US [patent_app_date] => 2015-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 8146 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14827674 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/827674
Rapid tests for the detection of inhibitors of enzymes and human exposure to the same Aug 16, 2015 Issued
Array ( [id] => 10684342 [patent_doc_number] => 20160030486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'PREPARATION OF COMPOSITIONS TO TREAT AND TREATMENT OF OSTEOARTHRITIS USING ADIPOSE-DERIVED STROMAL VASCULAR FRACTION CELLS' [patent_app_type] => utility [patent_app_number] => 14/823586 [patent_app_country] => US [patent_app_date] => 2015-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 25055 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14823586 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/823586
PREPARATION OF COMPOSITIONS TO TREAT AND TREATMENT OF OSTEOARTHRITIS USING ADIPOSE-DERIVED STROMAL VASCULAR FRACTION CELLS Aug 10, 2015 Abandoned
Array ( [id] => 13223161 [patent_doc_number] => 10125347 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-13 [patent_title] => Method for stimulating the expression of specific tissue morphologies in filamentous fungi [patent_app_type] => utility [patent_app_number] => 14/745881 [patent_app_country] => US [patent_app_date] => 2015-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2684 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14745881 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/745881
Method for stimulating the expression of specific tissue morphologies in filamentous fungi Jun 21, 2015 Issued
Array ( [id] => 13168363 [patent_doc_number] => 10100286 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-16 [patent_title] => Systems and methods of dissociating aggregate spheres of cells [patent_app_type] => utility [patent_app_number] => 14/744200 [patent_app_country] => US [patent_app_date] => 2015-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 15 [patent_no_of_words] => 5332 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 277 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14744200 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/744200
Systems and methods of dissociating aggregate spheres of cells Jun 18, 2015 Issued
Array ( [id] => 12238506 [patent_doc_number] => 20180071370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-15 [patent_title] => 'METHOD TO IMPROVE SAFETY AND EFFICACY OF ANTI-CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 15/530666 [patent_app_country] => US [patent_app_date] => 2015-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11024 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15530666 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/530666
Method to improve safety and efficacy of anti-cancer therapy Jun 18, 2015 Issued
Array ( [id] => 10712695 [patent_doc_number] => 20160058842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-03 [patent_title] => 'FACTOR VIII POLYMER CONJUGATES' [patent_app_type] => utility [patent_app_number] => 14/736870 [patent_app_country] => US [patent_app_date] => 2015-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8816 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14736870 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/736870
FACTOR VIII POLYMER CONJUGATES Jun 10, 2015 Abandoned
Array ( [id] => 16406962 [patent_doc_number] => 10815506 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-27 [patent_title] => Production of fatty acid alkyl esters with caustic treatment [patent_app_type] => utility [patent_app_number] => 15/312230 [patent_app_country] => US [patent_app_date] => 2015-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15978 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15312230 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/312230
Production of fatty acid alkyl esters with caustic treatment May 27, 2015 Issued
Array ( [id] => 11744251 [patent_doc_number] => 20170198323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-13 [patent_title] => 'ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER' [patent_app_type] => utility [patent_app_number] => 15/313285 [patent_app_country] => US [patent_app_date] => 2015-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38121 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313285 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/313285
ENZYMATIC SYNTHESIS OF SOLUBLE GLUCAN FIBER May 21, 2015 Abandoned
Array ( [id] => 10362170 [patent_doc_number] => 20150247176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-03 [patent_title] => 'STARCH SPHERULITES HAVING CONTROLLED ENZYMATIC DIGESTION' [patent_app_type] => utility [patent_app_number] => 14/714457 [patent_app_country] => US [patent_app_date] => 2015-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7274 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14714457 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/714457
Starch spherulites having controlled enzymatic digestion May 17, 2015 Issued
Array ( [id] => 15160765 [patent_doc_number] => 10485855 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-26 [patent_title] => Demonstrable efficacy across or within patient populations [patent_app_type] => utility [patent_app_number] => 14/702269 [patent_app_country] => US [patent_app_date] => 2015-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10424 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14702269 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/702269
Demonstrable efficacy across or within patient populations Apr 30, 2015 Issued
Array ( [id] => 10331945 [patent_doc_number] => 20150216949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-06 [patent_title] => 'METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM' [patent_app_type] => utility [patent_app_number] => 14/685628 [patent_app_country] => US [patent_app_date] => 2015-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9564 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14685628 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/685628
Methods of treating cancer of the central nervous system Apr 13, 2015 Issued
Menu